The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses

By J. Deeken, Wolfgang Löscher. Clinical Cancer Research, 2007

712 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/bee221a2504cb839e5e0b880fbdfb40c459fee77

Citations in the corpus

• The blood-brain barrier in health and chronic neurodegenerative disorders. (2008, neutral): “…AA and monocarboxylic acids (lactate, pyruvate, ketone bodies); nucleosides (adenosine, guanosine, uridine); purines (adenine, guanine); amines (choline); and vitamins (Hawkins et al., 2006; Simpson et al., 2007; Ohtsuki and Terasaki, 2007; Deeken and Loscher, 2007; Spector and Johanson, 2007).”
• Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer (2010, neutral): “One of the reasons listed for the failure of brain chemotherapy is presence of the blood–brain barrier (BBB), which is located at the brain vascular endothelium (14).”